RSC postpones Othello while leading actor Sharon D Clarke has cancer treatment
The Royal Shakespeare Company (RSC) has postponed its production of Othello, scheduled for February 13 to April 3, 2027, at the Swan theatre in Stratford-upon-Avon. The decision was made because the leading actor, Olivier-winning Sharon D Clarke, will be undergoing cancer treatment.

Briefing Summary
AI-generatedThe Royal Shakespeare Company (RSC) has postponed its production of Othello, scheduled for February 13 to April 3, 2027, at the Swan theatre in Stratford-upon-Avon. The decision was made because the leading actor, Olivier-winning Sharon D Clarke, will be undergoing cancer treatment. Clarke expressed gratitude for the RSC's understanding and support. The RSC stated that ticket holders will receive automatic refunds and a replacement production will be announced later. Director Monique Touko and RSC co-artistic directors Daniel Evans and Tamara Harvey sent well wishes to Clarke and emphasized her integral role in the production's reimagining through the lens of misogynoir.
Article analysis
Model · rule-basedKey claims
5 extractedSharon D Clarke described the RSC staff's support as 'understanding, love, support and healing energy'.
The RSC's production of Othello reimagines the story through the lens of misogynoir, set in a climate-threatened future with a Black lesbian in power.
Sharon D Clarke is undergoing treatment for cancer.
The production was scheduled to run from February 13 to April 3, 2027, at the Swan theatre in Stratford-upon-Avon.
The Royal Shakespeare Company (RSC) has postponed its production of Othello starring Sharon D Clarke due to her cancer treatment.